267 related articles for article (PubMed ID: 21497135)
1. Prolyl cis/trans isomerase signalling pathways in cancer.
Theuerkorn M; Fischer G; Schiene-Fischer C
Curr Opin Pharmacol; 2011 Aug; 11(4):281-7. PubMed ID: 21497135
[TBL] [Abstract][Full Text] [Related]
2. Peptidyl-prolyl isomerases: functionality and potential therapeutic targets in cardiovascular disease.
Rostam MA; Piva TJ; Rezaei HB; Kamato D; Little PJ; Zheng W; Osman N
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):117-24. PubMed ID: 25377120
[TBL] [Abstract][Full Text] [Related]
3. Computational perspective and evaluation of plausible catalytic mechanisms of peptidyl-prolyl cis-trans isomerases.
Ladani ST; Souffrant MG; Barman A; Hamelberg D
Biochim Biophys Acta; 2015 Oct; 1850(10):1994-2004. PubMed ID: 25585011
[TBL] [Abstract][Full Text] [Related]
4. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
Stifani S
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
[TBL] [Abstract][Full Text] [Related]
5. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.
Hennig L; Christner C; Kipping M; Schelbert B; Rücknagel KP; Grabley S; Küllertz G; Fischer G
Biochemistry; 1998 Apr; 37(17):5953-60. PubMed ID: 9558330
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl prolyl cis/trans-isomerases: comparative reactivities of cyclophilins, FK506-binding proteins, and parvulins with fluorinated oligopeptide and protein substrates.
Golbik R; Yu C; Weyher-Stingl E; Huber R; Moroder L; Budisa N; Schiene-Fischer C
Biochemistry; 2005 Dec; 44(49):16026-34. PubMed ID: 16331962
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological targeting of catalyzed protein folding: the example of peptide bond cis/trans isomerases.
Edlich F; Fischer G
Handb Exp Pharmacol; 2006; (172):359-404. PubMed ID: 16610367
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
10. Prolyl cis-trans isomerization as a molecular timer.
Lu KP; Finn G; Lee TH; Nicholson LK
Nat Chem Biol; 2007 Oct; 3(10):619-29. PubMed ID: 17876319
[TBL] [Abstract][Full Text] [Related]
11. The Trypanosoma cruzi PIN1 gene encodes a parvulin peptidyl-prolyl cis/trans isomerase able to replace the essential ESS1 in Saccharomyces cerevisiae.
Erben ED; Daum S; Téllez-Iñón MT
Mol Biochem Parasitol; 2007 Jun; 153(2):186-93. PubMed ID: 17418434
[TBL] [Abstract][Full Text] [Related]
12. Multidomain Peptidyl Prolyl cis/trans Isomerases.
Schiene-Fischer C
Biochim Biophys Acta; 2015 Oct; 1850(10):2005-16. PubMed ID: 25445709
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
[TBL] [Abstract][Full Text] [Related]
14. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
15. Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.
Perrucci GL; Gowran A; Zanobini M; Capogrossi MC; Pompilio G; Nigro P
Cardiovasc Res; 2015 Jun; 106(3):353-64. PubMed ID: 25750190
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-specific prolyl isomerization: is there an underlying theme?
Wulf G; Finn G; Suizu F; Lu KP
Nat Cell Biol; 2005 May; 7(5):435-41. PubMed ID: 15867923
[TBL] [Abstract][Full Text] [Related]
17. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
Marsolier J; Weitzman JB
Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
[TBL] [Abstract][Full Text] [Related]
18. Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases.
Fanghänel J; Fischer G
Front Biosci; 2004 Sep; 9():3453-78. PubMed ID: 15353370
[TBL] [Abstract][Full Text] [Related]
19. Biological Function of Pin1 in Vivo and Its Inhibitors for Preclinical Study: Early Development, Current Strategies, and Future Directions.
He S; Li L; Jin R; Lu X
J Med Chem; 2023 Jul; 66(14):9251-9277. PubMed ID: 37438908
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
